The Pennant (PNTG) - 2025 Q4 - Annual Report

Revenue Growth and Market Trends - Home health and hospice services revenue grew by 336.3% from 2016 to 2025, with a compounded annual growth rate (CAGR) of 15.9%[39] - The home health market is projected to grow at a CAGR of 8.0% from 2024 to 2030, and the hospice industry is expected to grow at a CAGR of 8.1% during the same period[47] - The senior living market is anticipated to expand at a CAGR of 4.2% between 2024 to 2030[47] Company Operations and Growth Strategy - As of December 31, 2025, the company operated 172 home health and hospice agencies, a 341.0% increase since 2016[43] - The company provided senior living services in 63 communities with 4,428 total available units as of December 31, 2025[32] - The company aims to leverage its operational capabilities to expand partnerships and improve clinical outcomes through data analytics[37] - The disciplined acquisition strategy has been integral to the company's past success and future growth plans, focusing on strategic and underperforming operations[35] - The company plans to continue driving organic growth and acquiring additional operations in existing and new markets in a disciplined manner[38] - The company operated 172 home health and hospice agencies and 63 senior living communities across 16 states as of December 31, 2025[75] Revenue Sources and Payor Mix - Revenue from Medicare accounted for 48.4% of total revenue in 2025, while Medicaid contributed 13.1%[59] - Approximately 62.5%, 64.7%, and 66.9% of home health and hospice segment revenue was generated from Medicare in 2025, 2024, and 2023, respectively[31] - The blended payor mix as of December 31, 2025, was 48.4% Medicare, 13.1% Medicaid, 15.0% managed care, and 23.5% private pay and other sources[75] - Home health services generated 77.3% of total revenue, while senior living services accounted for 22.7% for the year ended December 31, 2025[75] - The company’s senior living services revenue is primarily derived from private pay residents, with Medicaid potentially supplementing payments[118] Quality and Compliance - The average CMS five-star quality rating for home health agencies was 4.2 out of 5, significantly higher than the industry average of 3.0 stars[74] - Home health agencies achieved an average of 4.2 out of 5 stars in the CMS Quality of Patient Care Star Rating, compared to the industry average of 3.0 stars[93] - Home health agencies must submit quality reporting data through OASIS assessments within 30 days, or face a 2% reduction in annual payment updates[91] - As of October 1, 2023, hospice agencies that fail to submit required CAHPS survey data incur a 4% reduction in their annual base rate payment update[92] - Hospice agencies that do not meet quality reporting requirements face a 4% reduction in the annual market basket update for the next fiscal year[104] Financial Impacts and Regulatory Environment - The HH Payment Final Rule for 2026 resulted in a net payment update percentage of -1.3%, leading to an estimated decrease of $220 million in payments across all home health providers compared to fiscal year 2025[84] - The Hospice Payment Final Rule for 2026 included a payment update percentage of 2.6%, resulting in an estimated increase of $750 million in payments across all hospice providers compared to fiscal year 2025[85] - Approximately 68.3% of total expenses were payroll-related for the year ended December 31, 2025[78] - A 1.0% change in interest rates would result in an annual interest expense change of approximately $1.8 million based on the company's long-term debt as of December 31, 2025[272] - The company has a borrowing capacity of $250.0 million under the Amended Credit Agreement with a syndicate of banks[272] Competition and Market Challenges - The company faces increased competition from local and national providers, which may limit its ability to attract and retain patients and residents[67] - Home health agencies in certain states must obtain Certificates of Need (CON) for expansion, impacting market entry and service changes[105] Regulatory Compliance and Reporting - The company is subject to extensive regulatory inspections, with unannounced surveys occurring at least annually at independent operating subsidiaries[112] - The company must comply with HIPAA regulations, which impose significant costs for maintaining patient health information confidentiality[115] - The company faces potential sanctions from CMS or state regulators if operations with poor regulatory histories are acquired[114] - The company is required to file reports with the SEC, including annual reports on Form 10-K and quarterly reports on Form 10-Q[121] - The company is subject to federal and state antitrust laws, with increasing enforcement activity noted in the healthcare sector[117] - The company must maintain compliance with various environmental laws and regulations affecting its senior living operations[119] - Failure to report standardized assessment data under the IMPACT Act may lead to a 2% reduction in market basket prices for post-acute care providers[103] Employee and Workforce Information - The company employs approximately 9,700 employees across its independent operating subsidiaries and Service Center as of December 31, 2025[76]

The Pennant (PNTG) - 2025 Q4 - Annual Report - Reportify